Literature DB >> 26874707

Unprotected Left Main Disease: Indications and Optimal Strategies for Percutaneous Intervention.

Jun Li1,2, Sandeep M Patel1,2, Manish A Parikh3, Sahil A Parikh4,5.   

Abstract

OPINION STATEMENT: Although the incidence of left main (LM) coronary artery disease is relatively low in patients undergoing routine angiography, it is a common presentation in patients with acute coronary syndromes. With the current interventional tools and techniques, percutaneous intervention for LM disease has become a viable alternative to the traditional coronary artery bypass grafting. Factors that contribute to the success and appropriateness of percutaneous intervention for LM disease include coronary anatomy and patient-specific factors such as left ventricular function. Multiple considerations should be taken into account prior to intervention, including hemodynamic support if necessary, intravascular imaging to guide therapy, and stent technique. This review provides an overview of the current body of literature to support the use of percutaneous intervention in LM disease and serves as guideline for the interventionalist approaching LM revascularization.

Entities:  

Keywords:  Bifurcation stenting; Hemodynamic support; Percutaneous coronary intervention; Unprotected left main disease

Year:  2016        PMID: 26874707     DOI: 10.1007/s11936-016-0441-2

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  92 in total

1.  The first patient to undergo coronary angioplasty--23-year follow-up.

Authors:  B Meier
Journal:  N Engl J Med       Date:  2001-01-11       Impact factor: 91.245

2.  Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis.

Authors:  Enno Boudriot; Holger Thiele; Thomas Walther; Christoph Liebetrau; Peter Boeckstegers; Tilmann Pohl; Bruno Reichart; Harald Mudra; Florian Beier; Brigitte Gansera; Franz-Josef Neumann; Michael Gick; Thomas Zietak; Steffen Desch; Gerhard Schuler; Friedrich-Wilhelm Mohr
Journal:  J Am Coll Cardiol       Date:  2011-02-01       Impact factor: 24.094

3.  Single-vessel versus bifurcation stenting for the treatment of distal left main coronary artery disease in the drug-eluting stenting era. Clinical and angiographic insights into the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registries.

Authors:  Marco Valgimigli; Patrizia Malagutti; Gaston A Rodriguez Granillo; Keiichi Tsuchida; Héctor M Garcia-Garcia; Carlos A G van Mieghem; Willem J Van der Giessen; Pim De Feyter; Peter de Jaegere; Ron T Van Domburg; Patrick W Serruys
Journal:  Am Heart J       Date:  2006-11       Impact factor: 4.749

4.  Intravascular ultrasound assessment of distal left main bifurcation disease: the importance of the polygon of confluence of the left main, left anterior descending, and left circumflex arteries.

Authors:  Soo-Jin Kang; Gary S Mintz; Jun-Hyok Oh; Duk-Woo Park; Seung-Whan Lee; Young-Hak Kim; Cheol Whan Lee; Seong-Wook Park; Seung-Jung Park
Journal:  Catheter Cardiovasc Interv       Date:  2013-03-28       Impact factor: 2.692

5.  Percutaneous coronary intervention versus coronary artery bypass graft surgery in left main coronary artery disease: a meta-analysis of randomized clinical data.

Authors:  Davide Capodanno; Gregg W Stone; Marie C Morice; Theodore A Bass; Corrado Tamburino
Journal:  J Am Coll Cardiol       Date:  2011-09-27       Impact factor: 24.094

6.  Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.

Authors:  Friedrich W Mohr; Marie-Claude Morice; A Pieter Kappetein; Ted E Feldman; Elisabeth Ståhle; Antonio Colombo; Michael J Mack; David R Holmes; Marie-angèle Morel; Nic Van Dyck; Vicki M Houle; Keith D Dawkins; Patrick W Serruys
Journal:  Lancet       Date:  2013-02-23       Impact factor: 79.321

7.  Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II.

Authors:  Carlos M Campos; David van Klaveren; Vasim Farooq; Charles A Simonton; Arie-Pieter Kappetein; Joseph F Sabik; Ewout W Steyerberg; Gregg W Stone; Patrick W Serruys
Journal:  Eur Heart J       Date:  2015-01-12       Impact factor: 29.983

Review 8.  Current management of left main coronary artery disease.

Authors:  Jean Fajadet; Alaide Chieffo
Journal:  Eur Heart J       Date:  2012-01       Impact factor: 29.983

9.  Randomized Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: 5-Year Outcomes of the PRECOMBAT Study.

Authors:  Jung-Min Ahn; Jae-Hyung Roh; Young-Hak Kim; Duk-Woo Park; Sung-Cheol Yun; Pil Hyung Lee; Mineok Chang; Hyun Woo Park; Seung-Whan Lee; Cheol Whan Lee; Seong-Wook Park; Suk Jung Choo; CheolHyun Chung; JaeWon Lee; Do-Sun Lim; Seung-Woon Rha; Sang-Gon Lee; Hyeon-Cheol Gwon; Hyo-Soo Kim; In-Ho Chae; Yangsoo Jang; Myung-Ho Jeong; Seung-Jea Tahk; Ki Bae Seung; Seung-Jung Park
Journal:  J Am Coll Cardiol       Date:  2015-03-15       Impact factor: 24.094

10.  Optical coherence tomography versus intravascular ultrasound to evaluate coronary artery disease and percutaneous coronary intervention.

Authors:  Hiram G Bezerra; Guilherme F Attizzani; Vasile Sirbu; Giuseppe Musumeci; Nikoloz Lortkipanidze; Yusuke Fujino; Wei Wang; Sunao Nakamura; Andrej Erglis; Giulio Guagliumi; Marco A Costa
Journal:  JACC Cardiovasc Interv       Date:  2013-03       Impact factor: 11.195

View more
  1 in total

Review 1.  Left Main Coronary Artery Interventions.

Authors:  Mirvat Alasnag; Lina Yaqoub; Ammar Saati; Khaled Al-Shaibi
Journal:  Interv Cardiol       Date:  2019-11-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.